Diagnostics pre-clinical services program
Ended Awarded Last action
- Contract number
- 75N93024F00001
- Awardee
-
Resourcepath, LLC UEI PAJNWLGPK753
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $746,197
Award facts
- Opportunity
-
- E19 Solicitation number
- Contract value 90% obligated
-
- $746,197.00 Current, with exercised options
- $828,484.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Sterling, VA, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $746,197 |
About this award
Resourcepath, LLC, a woman-owned small business, was awarded a $3,500 firm fixed price delivery order by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. This delivery order is part of a larger indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle titled "DIAGNOSTICS PRE-CLINICAL SERVICES PROGRAM" with a total potential value of $12 million and a period of performance through June 2030. Under this IDIQ contract, Resourcepath will provide pre-clinical diagnostic services to support the development of in vitro diagnostic products, such as product development processes and documentation, recombinant proteins and monoclonal antibodies, biochemical reagents, clinical specimens and bacterial isolates, next-generation sequencing, immunoassays and nucleic acid amplification assays, and pre-pilot and pilot-scale GMP manufacturing services. No set-aside designation was indicated for this specific delivery order.
Quick answers
Who was awarded contract 75N93024F00001?
75N93024F00001 was awarded to Resourcepath, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 20, 2023.
How much is contract 75N93024F00001 worth?
The government has obligated $746,197 on 75N93024F00001. Its potential value, with all options, is $828,484.
Is contract 75N93024F00001 an order under another contract?
Yes. 75N93024F00001 is a delivery order under 75N93023D00018, an indefinite delivery contract.
Was contract 75N93024F00001 competed?
The extent of competition for 75N93024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award